V. Moreno Garcia - Fdn Jimenez Diaz Hosp, START Madrid FJD, Oncol, Madrid, Spain

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

First-line ADP-A2M4CD8 T-cell Receptor T-cell Therapy plus Pembrolizumab in Head and Neck Cancers: An Additional Cohort of the Phase 1 SURPASS Trial

A. Ho, A. Garcia-Consuegra, J. Saro, A. Sauer, S. Cristiani, F.E. Brophy, S. Streets, E. Norry, M. Gillison, J. Charlson, M. Bover, J. Zugazagoitia,

International Journal of Radiation Oncology*Biology*Physicsno. 5 (2024): e84-e85

引用0浏览0引用

61MO Phase Ia/Ib study of the MDM2-p53 antagonist brigimadlin (BI 907828) in advanced solid tumours: Overall safety, and efficacy in patients (pts) with well-differentiated liposarcoma (WDLPS)

P. Reichardt, P. Schöffski, P. Lorusso, N. Yamamoto,V. Moreno Garcia, I. Lugowska, U. Lauer, N. Somaiah, C. Hu, H.T. Landsteiner, G. Jayadeva, M. Gounder

ESMO Open (2024)

引用0浏览0引用

40P Bioinformatic evaluation of the transcriptomic and immunologic profile of prostate tumors with high expression of kallikrein-2

I. Moreno Candilejo, L. Paniagua Herranz,B. Doger de Spéville, C. Diaz-Tejeiro, C. Nieto-Jimenez, A. Sanvicente,J. Ramon,V. Moreno Garcia, E. Calvo,A. Ocana Fernandez

Annals of Oncology (2023): S199-S199

引用0浏览0引用

500O Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

M. Vieito Villar,J.M. Sepúlveda Sánchez,V. Moreno Garcia, G. Lombardi, A. Stradella,R.H. Dahlrot,C.A. Haslund, M. Geurts, E. Pineda, P. Brandal,F.Y.F.L. De Vos,M.A. Vaz Salgado,

Annals of Oncology (2023): S392-S392

引用0浏览0引用

1045P Safety and preliminary clinical activity of JNJ-78306358 (JNJ-358), an HLA-G and CD3 bispecific antibody, for the treatment of advanced stage solid tumor

R. Geva,M. Vieito Villar, J. ramon, R. Perets, M. Pedregal,E. Corral de la Fuente,B. Doger de Spéville, E. Calvo, J. Bardina, E. Garralda, R.J. Brown, J. Gregor,

Annals of Oncology (2023): S633-S634

引用0浏览0引用

673P A phase I dose-escalation and expansion study evaluating the safety and efficacy of the MDM2–p53 antagonist brigimadlin (BI 907828) in patients (pts) with solid tumours

P. Schoeffski,P. Lorusso,N. Yamamoto,I. Lugowska,V. Moreno Garcia, U. Lauer, C. Hu, G. Jayadeva, M. Lahmar,M. Gounder

Annals of Oncology (2023): S472-S473

引用0浏览0引用

887P Antitumor activity of the radioenhancer NBTXR3 on injected lesions to estimate overall survival: Exploratory analyses from a phase I in cisplatin-ineligible locally advanced HNSCC patients

C. Le Tourneau, Z. Takacsi-Nagy, X. Liem, V. Calugaru,V. Moreno Garcia, E. Calvo, S. Salas,B. Doger de Spéville, A. Dubray-Vautrin, X. Mirabel, N. Badois, A. Chilles,

Annals of Oncology (2023): S568-S569

引用0浏览0引用

1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial

B.J. Solomon, A. Drilon, J.J. Lin, L. Bazhenova, K. Goto,J. De Langen,D-W. Kim, J. Wolf, C. Springfeld, S. Popat,D.W-T. Lim, C.S. Baik,

Annals of Oncology (2023): S787-S788

引用0浏览0引用

Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)

P. Bossi, G. Minuti, I. Brana,V. Moreno Garcia, V. Boni, P. Jamme, J. A. Call, C. Yan, B. Barasa, P. Doze, A. K. Joe, G. Laus,

Annals of Oncology (2023): S1610-S1611

引用0浏览0引用

655O Phase Ib study of cofetuzumab pelidotin, an anti-PTK7 antibody-drug conjugate, in patients with PTK7-expressing recurrent non-small cell lung cancer (rNSCLC)

B.C. Cho,M.L. Johnson, J. Bar, E. Schaefer, K. Yoh, A. Zer, M.T. Moskovitz,S-H. Lee,V. Moreno Garcia,M.J. De Miguel Luken, Y. Okuma, J-H. Kim,

Annals of Oncology（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn